Stock Expert AI
DOCRF company logo

DOCRF: AI 评分 38/100 — AI 分析 (4月 2026)

CloudMD Software & Services Inc. is a healthcare technology company operating in North America. It provides a range of digital health solutions, clinic services, and enterprise health solutions.

Key Facts: AI Score: 38/100 Sector: Healthcare

公司概况

概要:

CloudMD Software & Services Inc. is a healthcare technology company operating in North America. It provides a range of digital health solutions, clinic services, and enterprise health solutions.
CloudMD Software & Services Inc. is a North American healthcare technology company delivering digital health, clinic, and enterprise solutions. It operates through three segments, offering services like virtual care, electronic medical records, and mental health support. The company's focus is on integrating technology to enhance healthcare delivery and patient outcomes.

DOCRF是做什么的?

CloudMD Software & Services Inc., established in 2013 and formerly known as Premier Health Group Inc., rebranded in February 2020 to reflect its focus on cloud-based healthcare solutions. Headquartered in Vancouver, Canada, CloudMD operates as a healthcare technology company in North America. The company is structured into three primary segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. These segments provide a comprehensive suite of services, including mental health support, healthcare navigation, rehabilitation and assessments, education, absence management, and occupational health. CloudMD also offers billing and electronic medical records solutions, along with MyHealthAccess, a patient portal for online appointment booking and virtual care visits. Additionally, the company provides the Health and Wellness platform, which uses real-time data analysis to identify health indicators and compute risk scores. Other offerings include the iMD platform for educational resources, telemedicine services, and VisionPros, an online vision care platform. CloudMD operates a network of hybrid medical and rehabilitation clinics, as well as medical clinics for family practice and patient care. Its pharmacies retail prescription drugs, over-the-counter drugs, and other front store items. The company also provides patient support programs for disease management and clinical treatment outcomes, along with pharmaceutical logistic services.

DOCRF的投资论点是什么?

CloudMD Software & Services Inc. presents a speculative investment opportunity within the healthcare technology sector. The company's diverse service offerings, spanning digital health, clinic services, and enterprise solutions, position it to capitalize on the growing demand for integrated healthcare solutions. However, the company's negative profit margin of -91.5% raises concerns about its profitability and financial sustainability. Key growth catalysts include the expansion of its digital health services and the integration of its various platforms. Investors should closely monitor the company's ability to improve its financial performance and achieve profitability. As of March 16, 2026, the company's market capitalization is $0.01 billion, and the P/E ratio is -0.14.

DOCRF在哪个行业运营?

CloudMD operates within the rapidly evolving healthcare technology industry, which is experiencing significant growth due to increasing demand for digital health solutions and integrated healthcare services. The market is characterized by intense competition, with companies vying to provide innovative solutions that improve patient outcomes and reduce healthcare costs. CloudMD's focus on integrating digital health services, clinic services, and enterprise solutions positions it to capitalize on the trend towards more holistic and patient-centric care. Competitors include companies like BCBCF (WELL Health Technologies Corp.), CLSH (Clarus Therapeutics Holdings, Inc.), CRBKF (CareRx Corporation), FFLWF (Firefly Health, Inc.), and HBCNF (Helius Medical Technologies, Inc.).
Medical - Healthcare Information Services
Healthcare

DOCRF有哪些增长机遇?

  • Expansion of Digital Health Services: CloudMD can capitalize on the growing demand for virtual care and remote patient monitoring by expanding its digital health services. The telemedicine market, estimated to reach $460 billion by 2030, presents a significant opportunity for CloudMD to increase its market share. By investing in its MyHealthAccess platform and telemedicine capabilities, CloudMD can attract new customers and generate recurring revenue. Timeline: Ongoing.
  • Integration of Healthcare Platforms: CloudMD can drive growth by integrating its various healthcare platforms, such as MyHealthAccess, Health and Wellness, and iMD platform, to create a seamless and comprehensive healthcare experience for patients and providers. This integration can improve patient engagement, enhance clinical outcomes, and generate valuable data insights. The integrated healthcare market is expected to grow at a CAGR of 12% over the next five years. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: CloudMD can pursue strategic partnerships and acquisitions to expand its service offerings, geographic reach, and customer base. By partnering with other healthcare providers, technology companies, and pharmaceutical companies, CloudMD can create synergistic relationships that drive growth and innovation. The company can also acquire complementary businesses to expand its market presence and gain access to new technologies. Timeline: Ongoing.
  • Focus on Mental Health Solutions: CloudMD can capitalize on the growing awareness of mental health and the increasing demand for mental health services by focusing on its mental health solutions. The mental health market is estimated to reach $537.96 billion by 2030. By investing in its mental health support services and expanding its network of mental health professionals, CloudMD can attract new customers and generate recurring revenue. Timeline: Ongoing.
  • Expansion into New Geographic Markets: CloudMD can expand its operations into new geographic markets, such as the United States and Europe, to increase its customer base and revenue. The global healthcare market is expected to grow at a CAGR of 5% over the next five years. By establishing a presence in new markets, CloudMD can diversify its revenue streams and reduce its reliance on the Canadian market. Timeline: Upcoming: Within the next 3-5 years.
  • CloudMD operates through three segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions.
  • The company offers MyHealthAccess, a patient portal that enables online appointment booking and virtual care visits.
  • CloudMD provides the Health and Wellness platform, which uses real-time data analysis to identify health indicators and compute risk scores.
  • The company's gross margin is 23.2%.
  • CloudMD's market capitalization is $0.01 billion as of March 16, 2026.

DOCRF提供哪些产品和服务?

  • Provides enterprise health solutions, including mental health support and healthcare navigation.
  • Offers rehabilitation and assessments, education, absence management, and occupational health services.
  • Provides billing and electronic medical records solutions.
  • Offers MyHealthAccess, a patient portal for online appointment booking and virtual care visits.
  • Provides the Health and Wellness platform for real-time data analysis and risk score computation.
  • Offers the iMD platform for peer-reviewed educational resources.
  • Provides telemedicine services.
  • Operates VisionPros, an online vision care platform.

DOCRF如何赚钱?

  • Subscription fees for digital health platforms like MyHealthAccess and Health and Wellness.
  • Revenue from clinic services and pharmacies, including prescription drugs and over-the-counter sales.
  • Fees for enterprise health solutions, such as mental health support and healthcare navigation.
  • Revenue from telemedicine services and virtual care visits.
  • Employers seeking enterprise health solutions for their employees.
  • Patients seeking virtual care and online appointment booking.
  • Healthcare providers using billing and electronic medical records solutions.
  • Individuals seeking mental health support and healthcare navigation services.
  • Integrated platform offering a comprehensive suite of healthcare services.
  • Established network of clinics and pharmacies.
  • Proprietary technology platforms like MyHealthAccess and Health and Wellness.
  • Strong relationships with healthcare providers and employers.

什么因素可能推动DOCRF股价上涨?

  • Ongoing: Expansion of digital health services and telemedicine capabilities.
  • Ongoing: Integration of healthcare platforms to create a seamless patient experience.
  • Ongoing: Strategic partnerships and acquisitions to expand service offerings and geographic reach.
  • Ongoing: Focus on mental health solutions to capitalize on growing demand.
  • Upcoming: Potential expansion into new geographic markets within the next 3-5 years.

DOCRF的主要风险是什么?

  • Ongoing: Intense competition in the healthcare technology industry.
  • Potential: Regulatory changes impacting the healthcare sector.
  • Potential: Economic downturn affecting healthcare spending.
  • Potential: Technological obsolescence of existing platforms.
  • Ongoing: Negative profit margin and financial sustainability concerns.

DOCRF的核心优势是什么?

  • Comprehensive suite of healthcare services.
  • Integrated technology platform.
  • Established network of clinics and pharmacies.
  • Experienced management team.

DOCRF的劣势是什么?

  • Negative profit margin.
  • Limited brand recognition.
  • High reliance on acquisitions for growth.
  • OTC market listing.

DOCRF有哪些机遇?

  • Expansion of digital health services.
  • Strategic partnerships and acquisitions.
  • Focus on mental health solutions.
  • Expansion into new geographic markets.

DOCRF面临哪些威胁?

  • Intense competition.
  • Regulatory changes.
  • Economic downturn.
  • Technological obsolescence.

DOCRF的竞争对手是谁?

  • WELL Health Technologies Corp. — Focuses on EMR and telehealth services. — (BCBCF)
  • Clarus Therapeutics Holdings, Inc. — Specializes in hormone therapies. — (CLSH)
  • CareRx Corporation — Provides pharmacy services to seniors. — (CRBKF)
  • Firefly Health, Inc. — Offers virtual primary care services. — (FFLWF)
  • Helius Medical Technologies, Inc. — Develops neurostimulation therapies. — (HBCNF)

Key Metrics

  • MoonshotScore: 38/100

Company Profile

  • CEO: Karen Adams
  • Headquarters: Vancouver, CA
  • Employees: 224
  • Founded: 2018

AI Insight

AI analysis pending for DOCRF
  • OTC Tier: OTC Other
  • Disclosure Status: Unknown

常见问题

What does CloudMD Software & Services Inc. do?

CloudMD Software & Services Inc. operates as a healthcare technology company in North America, offering a range of digital health solutions, clinic services, and enterprise health solutions. The company's services include virtual care, electronic medical records, mental health support, and healthcare navigation. CloudMD aims to integrate technology to enhance healthcare delivery and improve patient outcomes, serving employers, patients, and healthcare providers through its various platforms and services.

What do analysts say about DOCRF stock?

AI analysis is currently pending for DOCRF. Generally, analysts would assess CloudMD's financial performance, growth potential, and competitive positioning within the healthcare technology sector. Key valuation metrics to consider include revenue growth, gross margin, and market capitalization. Investors should monitor analyst ratings and price targets to gain insights into market sentiment and potential investment opportunities, while understanding that DOCRF trades on the OTC market.

What are the main risks for DOCRF?

The main risks for CloudMD Software & Services Inc. include intense competition in the healthcare technology industry, potential regulatory changes impacting the healthcare sector, and the company's negative profit margin. Additionally, the company faces risks associated with technological obsolescence and the need to continually innovate to stay ahead of competitors. As an OTC-listed company, DOCRF carries additional risks related to liquidity, transparency, and regulatory oversight.

热门股票

查看全部股票 →